By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is that Occidental Petroleum (OXY) is a high-risk, high-beta bet on oil prices, with Berkshire Hathaway's involvement not necessarily signaling long-term conviction. The sale of OxyChem to Berkshire has left OXY as a more leveraged play on energy prices, with reduced defensive cushion and amplified risk for public shareholders.
Risk: OXY's heavy debt load and lack of defensive buffer make it a binary play on energy prices, with debt service becoming precarious if oil prices average around $65-70 through 2026.
Opportunity: None identified
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Warren Buffett is no longer the CEO of Berkshire Hathaway (NYSE: BRKA)(NYSE: BRKB). But his fingerprints are all over how the conglomerate does business. After all, Berkshire's investment activities are now overseen by a handful of handpicked lieutenants, all of whom spent years working directly with Buffett, mastering his investment style while bringing their own strengths.
There are plenty of stocks in Berkshire's portfolio that Buffett personally selected. One of Berkshire's biggest positions, in fact, was a favorite of Buffett's when he was at the helm. This under-the-radar oil stock remains relatively cheap despite Berkshire's heavy interest.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Buffett first bought shares of Occidental Petroleum (NYSE: OXY) for Berkshire's portfolio in the first quarter of 2019. He massively upped the stake in the fourth quarter of that year, only to sell the entire stake in the second quarter of 2020.
Buffett couldn't stay away for long, however. In March 2022, he purchased massive blocks of Occidental Petroleum over several trading sessions. He purchased even more shares on several occasions in May and June. While he did trim the position slightly later that year, Berkshire has been a consistent buyer of Occidental Petroleum stock nearly every quarter since.
What did Buffett love so much about Occidental Petroleum? Mainly, he adored the way the company was run. After reading the company's annual report, Buffett commented, "I read every word and said this is exactly what I would be doing." But Buffett was more than just bullish on Occidental Petroleum's management style. He was also a long-term oil bull. He once warned:
When you buy into a huge oil production company, how it works out is going to depend on the price of oil to a great extent. It's not going to be your geological home runs or super mistakes or anything like that. It is an investment that depends on the price of oil.
In a nutshell, Buffett thought that buying into an oil company nearly required a bullish stance on oil prices.
Fortunately, Buffett had revealed in 2011 where he thought oil prices were headed long-term. "You've stuck a lot of straws into the Earth, and it is a finite number," he said. "So, the one thing I can almost promise you is that oil will sell for a lot more someday."
Occidental Petroleum isn't the same company that Buffett originally purchased in 2019. In 2024, Occidental Petroleum added to its debt load with a $12 billion takeover of CrownRock, L.P., a mid-tier U.S. oil and gas producer. Then, in 2025, it sold its OxyChem chemicals division directly to Berkshire Hathaway in a $9.7 billion cash deal. The company also welcomed a new CEO on June 1.
Still, Berkshire Hathaway has held onto its entire position, refusing to trim its stake even after Buffett's departure. Trading at 17 times free cash flow, Occidental Petroleum stock isn't as cheap as it was when Buffett first started buying. But a 6% free-cash-flow yield remains respectable in an otherwise expensive market, especially if you believe ongoing geopolitical uncertainties will keep oil prices higher for longer.
Before you buy stock in Occidental Petroleum, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Occidental Petroleum wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $379,662! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,206,116!
Now, it’s worth noting Stock Advisor’s total average return is 886% — a market-crushing outperformance compared to 206% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of July 28, 2026. *
Ryan Vanzo has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Berkshire Hathaway. The Motley Fool recommends Occidental Petroleum. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Berkshire's stasis in OXY since 2022 plus richer valuation and added leverage make the stock less compelling than the article suggests."
The article frames Berkshire's continued holding in OXY as a Buffett-endorsed long-term oil bull bet trading at a 'respectable' 6% FCF yield. Yet context is missing: Buffett has not bought a single additional share since 2022, the position is now managed by successors, and OXY's balance sheet is heavier post-CrownRock. At 17x FCF in a world where Permian peers trade closer to 10-12x, the valuation already prices in sustained $70+ WTI. Geopolitical risk is real but OPEC+ spare capacity, U.S. shale response, and accelerating EV adoption could cap prices. The OxyChem sale to Berkshire itself looks like housekeeping rather than conviction.
If oil averages $80+ through 2028 on persistent Middle East disruption and slower green transition, OXY's debt-financed acreage and operating leverage could easily drive the stock to low-teens P/E and deliver 40-50% upside that the article underplays.
"The sale of the OxyChem division fundamentally transformed OXY from a diversified energy conglomerate into a highly sensitive, pure-play levered commodity bet, significantly increasing the stock's downside risk."
The article frames Occidental Petroleum (OXY) as a 'Buffett-approved' value play, but it ignores the structural shift created by the 2025 divestiture of OxyChem. By offloading its chemicals division—a vital, steady cash-flow hedge against the volatility of WTI crude—OXY has effectively become a 'pure-play' levered bet on oil prices. Trading at 17x free cash flow is hardly a bargain for a commodity producer with a heavy debt load from the CrownRock acquisition. Investors are no longer buying the diversified, vertically integrated energy firm Buffett originally targeted; they are buying a high-beta proxy for geopolitical risk that lacks the defensive cushion it once had.
If geopolitical instability leads to a sustained supply shock, OXY’s increased production capacity from the CrownRock deal could generate massive, unhedged upside that justifies the higher valuation multiple.
"Berkshire's passive holding of OXY under new management is not the same as Buffett's active accumulation, and the thesis entirely depends on oil prices that current market pricing does not reflect."
The article conflates Berkshire's continued holding with active conviction, which is sloppy. Yes, Berkshire bought OXY aggressively in 2022 and holds it now—but the article omits critical context: Berkshire's cash position has ballooned to $325B+ (record levels), and Todd Combs/Ted Weschler have shown less appetite for energy than Buffett. The 6% FCF yield sounds respectable until you ask: at what oil price? OXY's 2024 guidance assumed $70-80 WTI; current strip pricing for 2026-27 is materially lower. The CrownRock acquisition ($12B debt) and OxyChem sale to Berkshire ($9.7B) suggest OXY management is optimizing capital structure, not signaling embedded upside. Holding ≠ buying.
If geopolitical risk (Middle East, Russia sanctions, energy security) sustains $80+ oil through 2026-27, OXY's 17x FCF multiple is genuinely cheap, and Berkshire's silence on trimming despite record cash actually signals confidence in that scenario.
"OXY's value here hinges on sustained high oil prices and disciplined capex; without that, Berkshire's bet risks drift and underwhelming returns."
Odds are Berkshire’s Occidental bet rests on two pillars: Buffett’s imprimatur and an oil price backdrop that keeps cash flow robust. The article presents OXY as under the radar and cheap on a 17x free cash flow basis, with a 6% FCF yield. Yet the 12 billion CrownRock debt load and the sale of OxyChem to Berkshire signal a capital-allocation tilt that could limit upside if oil remains range-bound. With Buffett now out of the CEO chair, governance and strategic execution risk rise. The missing context: hedging, capex needs, and whether the geostrategic tension justifies a long-duration commodity bet.
Strongest counter: oil is cyclical and OXY’s 6% FCF yield can evaporate if oil prices retreat; the CrownRock debt and related refinancing risk intensify if cash flows falter, and Berkshire’s governance edge may not be as sharp without Buffett in the chair.
"The OxyChem sale to Berkshire itself amplifies OXY’s remaining leverage to oil prices, stripping away its former hedge."
Claude correctly flags the shift from Buffett to successors, but everyone underweights the $9.7B OxyChem sale to Berkshire itself. That transaction lets Berkshire extract chemical cash flows directly while leaving OXY as a higher-beta E&P vehicle. It’s not housekeeping; it’s de facto financial engineering that transfers downside protection to Berkshire and concentrates commodity risk for public shareholders.
"The OxyChem divestiture removes OXY's primary defensive buffer, leaving shareholders exposed to extreme downside risk if oil prices fail to sustain current levels."
Grok, your 'financial engineering' theory ignores the operational reality of the OxyChem sale. Berkshire didn't just buy a cash-flow stream; they bought a tax-advantaged asset that OXY couldn't optimize under its current debt covenants. By isolating the chemical business, OXY is essentially forced to deleverage through asset sales rather than organic growth. If oil prices dip, they lack the defensive buffer to service the CrownRock debt, making this a binary play on energy prices.
"The OxyChem sale asymmetrically transfers downside risk to public shareholders while Berkshire captures steady cash flows—a structure that only works if oil sustains $75+."
Gemini and Grok are both correct but talking past each other. The OxyChem sale IS financial engineering AND it forces OXY into a binary commodity bet. But neither flags the real trap: Berkshire now owns the defensive asset while public OXY shareholders own the levered upside with no cushion. If oil averages $65-70 through 2026, OXY's debt service becomes precarious. Berkshire's silence isn't confidence—it's optionality. They own the moat; retail owns the volatility.
"CrownRock debt and the OxyChem sale convert OXY into a binary oil-price bet with diminished downside protection for public shareholders."
Gemini overstresses the 'high-beta proxy' angle and misses CrownRock's roughly $12B debt plus the OxyChem sale. If oil slips, debt service tightens and refinancing becomes harder, eroding the 6% FCF yield. Berkshire now owns the chemical cash flows, reducing OXY's defensive cushion and amplifying public holders' exposure to oil-price shocks. Public equity isn't just leveraged oil exposure—it's a binary risk if prices fall and covenants bite.
The panel consensus is that Occidental Petroleum (OXY) is a high-risk, high-beta bet on oil prices, with Berkshire Hathaway's involvement not necessarily signaling long-term conviction. The sale of OxyChem to Berkshire has left OXY as a more leveraged play on energy prices, with reduced defensive cushion and amplified risk for public shareholders.
None identified
OXY's heavy debt load and lack of defensive buffer make it a binary play on energy prices, with debt service becoming precarious if oil prices average around $65-70 through 2026.